ThinkGenetic
ThinkGenetic uses AI and clinical expertise to reduce the time to diagnosis for genetic and rare conditions through solutions like FindEHR™ and FindSM™.
Company Overview
ThinkGenetic specializes in reducing the time to diagnosis for genetic and rare conditions by utilizing artificial intelligence. The company focuses on identifying patients at risk for rare diseases, offering solutions like FindEHR™ and FindSM™ to achieve these goals. ThinkGenetic serves a diverse range of clients, including biopharma companies, research institutions, healthcare providers, and advocacy organizations. The company's solutions are designed to be sensitive and specific enough to flag patients at increased risk, providing de-identified, HIPAA-compliant data to clients.
Services
ThinkGenetic offers two primary solutions: FindEHR™ and FindSM™. FindEHR™ leverages validated rare disease algorithms to analyze millions of Electronic Health Records (EHRs), identifying at-risk or diagnosed individuals. FindSM™ is an interactive patient risk-assessment module integrated into websites, providing insights for undiagnosed consumers concerned about their risk level. Both solutions are designed to support healthcare providers and patients in identifying and managing rare genetic conditions. These services are particularly valuable for clients in biopharma, healthcare, research, and advocacy.
Awards and Recognition
ThinkGenetic has earned significant recognition for its innovative solutions. The company's FindEHR™ tool was co-winner of the Horizon Prize, powered by MIT Solve. ThinkGenetic has also been voted best in the world by MIT and Horizon, underscoring its industry leadership in the field of rare disease diagnostics.
Collaborations
ThinkGenetic actively collaborates with organizations like the Guardian Research Network to accelerate diagnosis and treatment options for patients with genetic diseases and inherited predispositions to cancer. These collaborations enhance the company's ability to deploy its solutions effectively and expand its impact in the healthcare industry.
Technological Innovations
ThinkGenetic utilizes artificial intelligence and big data to identify patients at risk for rare genetic conditions. The company's algorithms demonstrate high sensitivity rates, ranging from 77 to 100% for pinpointing at-risk individuals. The FindEHR™ solution helps healthcare providers by applying these algorithms to vast amounts of Electronic Health Records, while the FindSM™ tool offers a chat-like experience for users to assess their risk and provides educational summaries to be shared with healthcare providers. These innovations highlight ThinkGenetic's commitment to leveraging technology for better health outcomes.